ONWARD Medical Announces 2024 General Meeting and Forward-Looking Resolutions

EINDHOVEN, the Netherlands, May 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a spearheading medical technology company focused on the development of spinal cord stimulation therapies, has proclaimed its convocation for the Annual General Meeting (AGM) of Shareholders to be held in 2024. The agenda consists of several proposed resolutions that are poised to augment the trajectory of the company in providing groundbreaking solutions to individuals with spinal cord injury (SCI). These therapies are engineered to restore movement, improve functionality, and ultimately, elevate the independence of affected individuals. ONWARD's commitment to innovation in the field of medical technology underscores its position as a vanguard in SCI treatments.

Agenda Highlights and Shareholder Discussions

The AGM will feature an in-depth review of the past year's achievements, which includes progress in clinical trials and collaborations, as well as the financial health of the company. It will also focus on the proposed resolutions which are aimed at reinforcing the company's governance and operational efficiency. Shareholders registered with the stock ticker ONWRF have shown particular interest in how these resolutions will shape the strategic direction of ONWARD and influence the market's reception of its medical contributions.

Financial Performance and Future Prospects

ONWARD has reported a robust financial performance over the previous fiscal year, enabling it to reinvest in its core technology and expand its reach to more patients. The AGM will also present an opportunity for shareholders to deliberate on the future financial strategies that will support continued growth and innovation. The company's prospects look promising, with ongoing clinical trials and the potential for new partnerships on the horizon.

ONWARD, Medical, AGM